GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dominari Holdings Inc (NAS:DOMH) » Definitions » Shiller PE Ratio

Dominari Holdings (Dominari Holdings) Shiller PE Ratio : (As of Apr. 25, 2024)


View and export this data going back to 1984. Start your Free Trial

What is Dominari Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Dominari Holdings Shiller PE Ratio Historical Data

The historical data trend for Dominari Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dominari Holdings Shiller PE Ratio Chart

Dominari Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Dominari Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Dominari Holdings's Shiller PE Ratio

For the Biotechnology subindustry, Dominari Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dominari Holdings's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dominari Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Dominari Holdings's Shiller PE Ratio falls into.



Dominari Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Dominari Holdings's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Dominari Holdings's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.29/129.4194*129.4194
=-1.290

Current CPI (Dec. 2023) = 129.4194.

Dominari Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -2,278.750 99.695 -2,958.182
201406 -947.190 100.560 -1,219.027
201409 -247.093 100.428 -318.424
201412 -106.946 99.070 -139.709
201503 -195.798 99.621 -254.364
201506 -1,933.410 100.684 -2,485.211
201509 -112.710 100.392 -145.300
201512 341.020 99.792 442.264
201603 -18.785 100.470 -24.198
201606 665.423 101.688 846.890
201609 -7.948 101.861 -10.098
201612 -141.610 101.863 -179.919
201703 -13.728 102.862 -17.272
201706 -27.455 103.349 -34.381
201709 5.780 104.136 7.183
201712 -11.560 104.011 -14.384
201803 -16.320 105.290 -20.060
201806 -3.400 106.317 -4.139
201809 -15.980 106.507 -19.418
201812 49.980 105.998 61.024
201903 -2.280 107.251 -2.751
201906 -5.100 108.070 -6.108
201909 -23.460 108.329 -28.027
201912 11.560 108.420 13.799
202003 -15.470 108.902 -18.385
202006 -1.190 108.767 -1.416
202009 -1.020 109.815 -1.202
202012 0.850 109.897 1.001
202103 -1.190 111.754 -1.378
202106 -0.260 114.631 -0.294
202109 -0.010 115.734 -0.011
202112 -0.340 117.630 -0.374
202203 -1.250 121.301 -1.334
202206 -1.180 125.017 -1.222
202209 -1.170 125.227 -1.209
202212 -1.320 125.222 -1.364
202303 -0.710 127.348 -0.722
202306 -1.790 128.729 -1.800
202309 -0.660 129.860 -0.658
202312 -1.290 129.419 -1.290

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Dominari Holdings  (NAS:DOMH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Dominari Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Dominari Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Dominari Holdings (Dominari Holdings) Business Description

Traded in Other Exchanges
Address
One Rockefeller Plaza, 11th Floor, New York, NY, USA, 10020
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing a therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore, and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company is also developing an antiviral platform, in which the compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.
Executives
Kyle Michael Wool director 650 5TH AVE, 35TH FLOOR, NEW YORK NY 10019
Christopher Franklin Devall officer: Chief Operating Officer DOMINARI HOLDINGS INC., ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK NY 10020
Anthony Hayes director, officer: Chief Executive Officer 1796 SHADY LANE, COLUMBIA SC 29206
George Way officer: Chief Financial Officer C/O DOMINARI HOLDINGS INC., 725 5TH AVENUE 23RD FLOOR, NEW YORK NY 10022
Soo Yu director ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK NY 10020
Tim S Ledwick director 10200 INNOVATION DRIVE, SUITE 300, MILWAUKEE WI 53226
Gregory James Blattner director ONE ROCKEFELLER PLAZA 11TH FLOOR, NEW YORK NY 10020
Paul Lemire director ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK NY 10020
Robert Frederick Dudley director ONE ROCKEFELLER PLAZA, 11TH FLOOR, NEW YORK NY 10020
Zanden Robert J Vander director 913 HIGH KNOLL WAY, TRAVELERS REST SC 29690
Eric Weisblum director 285 GRAND AVENUE, ENGLEWOOD NJ 07631
Howard E Goldberg director 781 THIRD AVENUE, KING OF PRUSSIA PA 194061409
Frank Reiner officer: Interim CFO 6430 ROCKLEDGE DRIVE, SUITE 503, BETHESDA MD 20817
Jeffrey Ballabon director 6430 ROCKLEDGE DRIVE, BETHESDA NY 20817
Richard Cohen officer: Chief Financial Officer C/O DUNE ENERGY, INC., TWO SHELL PLAZA, 777 WALKER STREET, SUITE 2300, HOUSTON TX 77002

Dominari Holdings (Dominari Holdings) Headlines